Dr. Scott Rocklage is an American entrepreneur and businessman. He attended the University of California, Berkley where he obtained his Bachelor of Science in chemistry. He then moved on to the Massachusets Institute of Technology. While attending classes there, he obtained his Ph.D. in chemistry. Dr. Scott Rocklage holds over 30 patents in the United States, which he either invented or co-invented. He has enriched several companies in his long career. He started out in healthcare companies early on. He has been appointed Chairman of the Board at the companies Cidara Therapeutics, Inc and Novra Therapeutics, Inc. Dr. Rocklage has a history of high-level positions in various companies. Scott Rocklage has served as CEO and President to Amersham Health, Executive Chairman and Co-President of Ilypsa, Inc., along with some research and design (R&D) departments. Dr. Rocklage currently works at 5AM Ventures. He joined 5AM Ventures in 2003 as a Venture Partner and has worked his way up to Managing Partner, a role he took on in late 2004. He also has entered six drug candidates into clinical trials, with the successful approval of three other drugs by the FDA and more information click here.
5AM Ventures was founded in 2002 and is based in California. 5AM Ventures is focused on investing in the early stages of life science companies. 5AM believes in a hands-on approach to starting and managing companies. The company takes on short-term leadership and operating roles with a focus on guiding the new companies and mentoring its employees to ensure success. The 5AM team is made up of people who are passionate about what to do and they have worked together for years to create a great working environment with great chemistry.
Dr. Scott Rocklage has revolutionized the healthcare industry. He has built a career that is very success-oriented and will continue to do so for years to come.